These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 20668135
1. Performance of the Abbott RealTime CT/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. Gaydos CA, Cartwright CP, Colaninno P, Welsch J, Holden J, Ho SY, Webb EM, Anderson C, Bertuzis R, Zhang L, Miller T, Leckie G, Abravaya K, Robinson J. J Clin Microbiol; 2010 Sep; 48(9):3236-43. PubMed ID: 20668135 [Abstract] [Full Text] [Related]
2. Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay. Cheng A, Qian Q, Kirby JE. J Clin Microbiol; 2011 Apr; 49(4):1294-300. PubMed ID: 21325546 [Abstract] [Full Text] [Related]
3. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs. Chernesky M, Jang D, Gilchrist J, Hatchette T, Poirier A, Flandin JF, Smieja M, Ratnam S. J Clin Microbiol; 2014 Jul; 52(7):2305-10. PubMed ID: 24696024 [Abstract] [Full Text] [Related]
4. [Usefulness of real-time PCR in detecting Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical swabs and first-voided urine specimens]. Hamasuna R, Kawai S, Ando Y, Ito K, Kurashima M, Nishimura H, Yamaguchi T, Yoshimura M, Kobayashi T, Muratani T, Matsumoto T. Kansenshogaku Zasshi; 2011 Jan; 85(1):1-7. PubMed ID: 21404599 [Abstract] [Full Text] [Related]
5. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Schachter J, Chernesky MA, Willis DE, Fine PM, Martin DH, Fuller D, Jordan JA, Janda W, Hook EW. Sex Transm Dis; 2005 Dec; 32(12):725-8. PubMed ID: 16314767 [Abstract] [Full Text] [Related]
6. [Usefulness of real-time PCR in detecting Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical swabs and first-voided urine specimens]. Hamasuna R, Kawai S, Ando Y, Ito K, Kurashima M, Nishimura H, Yamaguchi T, Yoshimura M, Kobayashi T, Muratani T, Matsumoto T. Kansenshogaku Zasshi; 2013 Sep; 87(5 Suppl 8):17-23. PubMed ID: 24475696 [Abstract] [Full Text] [Related]
7. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, Hardick A, Agreda P, Barnes M, Gaydos CA. J Clin Microbiol; 2009 Jun; 47(6):1663-7. PubMed ID: 19386838 [Abstract] [Full Text] [Related]
8. Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine. Taylor SN, Liesenfeld O, Lillis RA, Body BA, Nye M, Williams J, Eisenhut C, Hook EW, Van Der Pol B. Sex Transm Dis; 2012 Jul; 39(7):543-9. PubMed ID: 22706217 [Abstract] [Full Text] [Related]
9. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. Chernesky M, Freund GG, Hook E, Leone P, D'Ascoli P, Martens M. J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931 [Abstract] [Full Text] [Related]
10. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Moncada J, Schachter J, Hook EW, Ferrero D, Gaydos C, Quinn TC, Willis D, Weissfeld A, Martin DH. Sex Transm Dis; 2004 May; 31(5):273-7. PubMed ID: 15107628 [Abstract] [Full Text] [Related]
14. Comparison between the LCx Probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, The Netherlands. van Doornum GJ, Schouls LM, Pijl A, Cairo I, Buimer M, Bruisten S. J Clin Microbiol; 2001 Mar; 39(3):829-35. PubMed ID: 11230391 [Abstract] [Full Text] [Related]
15. Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study. Morris SR, Bristow CC, Wierzbicki MR, Sarno M, Asbel L, French A, Gaydos CA, Hazan L, Mena L, Madhivanan P, Philip S, Schwartz S, Brown C, Styers D, Waymer T, Klausner JD. Lancet Infect Dis; 2021 May; 21(5):668-676. PubMed ID: 33242473 [Abstract] [Full Text] [Related]